229 related articles for article (PubMed ID: 7661030)
1. A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification.
Spoto G; Berardi S; Ajerba G; De Laurentiis V
Adv Exp Med Biol; 1994; 370():815-20. PubMed ID: 7661030
[No Abstract] [Full Text] [Related]
2. Analysis of phosphodiesterase reaction mixtures by high-performance liquid chromatography.
Watterson DM; Lukas TJ
Methods Enzymol; 1988; 159():471-7. PubMed ID: 2842612
[No Abstract] [Full Text] [Related]
3. Reconsideration of the multiple cyclic nucleotide phosphodiesterases in bovine heart.
Donnelly TE
Biochem Biophys Res Commun; 1978 Jun; 82(3):964-70. PubMed ID: 212032
[No Abstract] [Full Text] [Related]
4. Theoretical analyses of the functioning of the high- and low-Km cyclic nucleotide phosphodiesterases in the regulation of the concentration of adenosine 3',5'-cyclic monophosphate in animal cells.
Fell DA
J Theor Biol; 1980 May; 84(2):361-85. PubMed ID: 6251314
[No Abstract] [Full Text] [Related]
5. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
6. Multiplicity within cyclic nucleotide phosphodiesterases.
Rybalkin SD; Beavo JA
Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
[No Abstract] [Full Text] [Related]
7. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide content and granule cell degeneration in the developing cerebellum of staggerer mice.
Spinka K; Farber DB; Lolley RN
J Neurochem; 1980 Jun; 34(6):1531-4. PubMed ID: 6103918
[No Abstract] [Full Text] [Related]
9. Chromatographic behavior of cyclic 3',5'-nucleotide phosphodiesterases on columns of immobilized inhibitors.
Mohindru A; Chenet A; Rhoads AR
Biochemistry; 1978 Aug; 17(16):3297-304. PubMed ID: 80229
[No Abstract] [Full Text] [Related]
10. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
Kincaid RL; Manganiello VC
Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
[No Abstract] [Full Text] [Related]
11. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
12. Drosophila cyclic nucleotide phosphodiesterases.
Davis RL; Kauvar LM
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
[No Abstract] [Full Text] [Related]
13. Cyclic nucleotide phosphodiesterases.
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
[No Abstract] [Full Text] [Related]
14. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
Perez de Gracia B; Rhoads AR; West WL
Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
[TBL] [Abstract][Full Text] [Related]
15. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
Stefanovich V
Neurochem Res; 1979 Dec; 4(6):681-7. PubMed ID: 232543
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
Guan WR; Cheung WY
Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844
[No Abstract] [Full Text] [Related]
17. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
19. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
Erneux C; Miot F
Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
[No Abstract] [Full Text] [Related]
20. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]